PDL BioPharma (PDLI)

Add to Watchlists Create an Alert
9.655 +0.06  +0.57% NASDAQ Jul 23, 5:00PM BATS Real time Currency in USD
View Full Chart
PDLI Price Chart
View All Events

PDLI Events

Date Type Description
12/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Dec 12 2014
09/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Sep 12 2014
06/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Jun 12 2014
05/12/2014 16:30 EDT Misc PDL BioPharma Inc 1Q2014 Earning Conference Call
05/12/2014 Earnings PDL BioPharma Inc 1Q2014 Earning Result. Estimate: 0.50.
03/12/2014 Misc PDL Biopharma Announces 2014 Regular Quarterly Dividends
03/03/2014 16:30 EST Misc PDL BioPharma, Inc. Q4 2013 Earning Conference Call
03/03/2014 Earnings PDL BioPharma, Inc. Q4 2013 Earning Result. Estimate: 0.41.
03/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Mar 12 2014
12/31/2013 Misc PDL Biopharma Provides Fourth Quarter 2013 Revenue Guidance of $109 Million
View All Performance Charts

PDLI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PDL BioPharma is up 26.47% over the last year vs S&P 500 Total Return up 19.65%, Durata Therapeutics up 62.61%, and Galena Biopharma up 71.75%.

Get Quote for

PDF Report for PDLI

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PDLI Pro Report PDF
Advertisement

Portfolio Strategies Featuring PDLI

Did PDL BioPharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PDLI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.pdl.com
  • IR Website: http://investor.pdl.com/
  • HQ Country: United States
  • HQ State/Province: Nevada
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

PDL BioPharma, Inc., is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.

PDLI Excel Add-In Codes

  • Name: =YCI("PDLI","name")
  • Description: =YCI("PDLI","description")
  • Sector: =YCI("PDLI","sector")
  • Industry: =YCI("PDLI","industry")
  • Est. Current Fiscal Year End: =YCI("PDLI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.